Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3375.

https://doi.org/10.1182/blood-2019-126893

Published: 2019

Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3438.

https://doi.org/10.1182/blood-2019-128507

Published: 2019

Journal Articles

The Abnormal Repression of Mir-375 Expression By Overlapping Epigenetic Dysregulations in Myelomas

Shotaro Tatekawa, MD, Yoshiaki Chinen, MD PhD, Yuji Shimura, MD PhD, Yayoi Matsumura-Kimoto, MD, Hisao Nagoshi, MD PhD, Tsutomu Kobayashi, MD PhD, Eri Kawata, MD PhD, Tomoko Narita, MD PhD, Masaki Ri, MD PhD, Hiroshi Handa, MD PhD, Nobuhiko Uoshima, MD PhD, Shinsuke Iida, MD PhD, Junya Kuroda, MD PhD

Blood (2016) 128 (22): 4460.

https://doi.org/10.1182/blood.V128.22.4460.4460

Published: 2016

Journal Articles

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Tsutomu Kobayashi, MD PhD, Junya Kuroda, MD PhD, Isao Yokota, PhD, Kazuna Tanba, MD, Tomohiko Taki, MD PhD, Takahiro Fujino, MD, Saeko Kuwahara, MD, Reiko Isa, MD, Junko Yamaguchi, MD, Eri Kawata, MD PhD, Teruaki Akaogi, MD, Hitoji Uchiyama, MD PhD, Hiroto Kaneko, MD, Nobuhiko Uoshima, MD PhD, Yutaka Kobayashi, MD PhD, Satoshi Teramukai, PhD, Masafumi Taniwaki

Blood (2015) 126 (23): 3877.

https://doi.org/10.1182/blood.V126.23.3877.3877

Published: 2015

Journal Articles

The Epigenetic Repression of Mir-375 Is the Dominant Mechanism for the Constitutive Activation of PDPK1/RSK2 Signaling Axis in Multiple Myeloma

Shotaro Tatekawa, MD, Junya Kuroda, MD PhD, Yoshiaki Chinen, MD, Yuji Shimura, MD, Hisao Nagoshi, MD, Tsutomu Kobayashi, MD PhD, Eri Kawata, MD PhD, Nobuhiko Uoshima, MD PhD, Hiroshi Handa, MD PhD, Masafumi Taniwaki

Blood (2015) 126 (23): 4182.

https://doi.org/10.1182/blood.V126.23.4182.4182

Published: 2015

Journal Articles

3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1) Is a Pivotal Cell Signaling Mediator in Multiple Myeloma

Yoshiaki Chinen, MD, Junya Kuroda, MD PhD, Yuji Shimura, MD PhD, Hisao Nagoshi, MD PhD, Miki Kiyota, MD PhD, Mio Yamamoto-Sugitani, MD PhD, Shinsuke Mizutani, MD, Natsumi Sakamoto, Masaki Ri, MD PhD, Eri Kawata, MD PhD, Tsutomu Kobayashi, MD PhD, Yosuke Matsumoto, MD PhD, Shigeo Horiike, MD PhD, Shinsuke Iida, Masafumi Taniwaki, MD PhD

Blood (2014) 124 (21): 4728.

https://doi.org/10.1182/blood.V124.21.4728.4728

Published: 2014

Journal Articles

Comparison Of Treatment Results Using High-Dose MTX Plus High-Dose AraC and High-Dose MTX Plus CHOP Regimens For Primary Central Nervous System Lymphoma

Hitoji Uchiyama, MD, PhD, Miki Kiyota, MD, Kazuna Tanba, MD, Eri Kawata, MD, PhD, Teruaki Akaogi, MD, Yutaka Kobayashi, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2013) 122 (21): 5102.

https://doi.org/10.1182/blood.V122.21.5102.5102

Published: 2013

Journal Articles

Galectin-9 Ameriorates Acute GVHD by Inducing T-Cell Apoptosis and Increasing Regulatory T Cell.

Kazuki Sakai, MD, Eri Kawata, MD, PhD, Eishi Ashihara, MD, PhD, Akira Yamauchi, MD, PhD, Shinya Kimura, MD, PhD, Hideyo Hirai, MD, PhD, Mitsuomi Hirashima, MD, PhD, Norio Yoshimura, MD, PhD, Taira Maekawa, MD, PhD

Blood (2009) 114 (22): 1338.

https://doi.org/10.1182/blood.V114.22.1338.1338

Published: 2009

Journal Articles

Automated and Rapid Detection of BCR-ABL Kinase Domain Mutations in IM Resistant Patients with Ph+ Leukemias.

Ruriko Tanaka, MMSc, Shinya Kimura, MD, PhD, Toshiya Hosomi, Mitsuharu Hirai, Rina Nagao, Asumi Yokota, MMSc, Yuri Kamitsuji, MD, PhD, Eri Kawata, MD, PhD, Hisayuki Yao, MD, Kazuki Sakai, MD, Hideyo Hirai, MD, PhD, Eishi Ashihara, MD, PhD, Souichi Adachi, MD, PhD, Taira Maekawa, MD, PhD

Blood (2009) 114 (22): 2590.

https://doi.org/10.1182/blood.V114.22.2590.2590

Published: 2009

NARROW

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

The Abnormal Repression of Mir-375 Expression By Overlapping Epigenetic Dysregulations in Myelomas

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

The Epigenetic Repression of Mir-375 Is the Dominant Mechanism for the Constitutive Activation of PDPK1/RSK2 Signaling Axis in Multiple Myeloma

3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1) Is a Pivotal Cell Signaling Mediator in Multiple Myeloma

Comparison Of Treatment Results Using High-Dose MTX Plus High-Dose AraC and High-Dose MTX Plus CHOP Regimens For Primary Central Nervous System Lymphoma

Galectin-9 Ameriorates Acute GVHD by Inducing T-Cell Apoptosis and Increasing Regulatory T Cell.

Automated and Rapid Detection of BCR-ABL Kinase Domain Mutations in IM Resistant Patients with Ph+ Leukemias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only